The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients-Reference-Cited by-同舟云学术

The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients

Published:2020-08-27 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Yuan Jia-qi,Ding Nian-hua,Xiao Zhi

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference43 articles.

1. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells;Bartucci;Oncogene,2015

2. Genes that mediate breast cancer metastasis to the brain;Bos;Nature,2009

3. YAP1 increases organ size and expands undifferentiated progenitor cells;Camargo;Curr. Biol.,2007

4. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells;Chan;Cancer Res.,2008

5. A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis;Chen;Genes Dev.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases;Signal Transduction and Targeted Therapy;2023-11-13

2. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer;Veterinary and Comparative Oncology;2023-09-14

3. YAP/TAZ: Molecular pathway and disease therapy;MedComm;2023-08

4. Targeting the YAP/TAZ mechanotransducers in solid tumour therapeutics;Journal of Cellular and Molecular Medicine;2023-05-25

5. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer;British Journal of Cancer;2023-02-09